Loading…
This event has ended. Visit the official site or create your own event on Sched.
Learn the latest cancer care information to benefit your patients and earn up to 30 CNE contact hours! Register now at congress.ons.org.
Back To Schedule
Saturday, April 30 • 11:15am - 12:15pm
A New Treatment Option for Patients With Multiple Myeloma Who Have Failed 3 or More Previous Therapies* *Double-Refractory to a PI and an Immunomodulatory Agent

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
This program is sponsored by Janssen Biotech
Saturday April 30, 2016 11:15am - 12:15pm CDT
Learning Hall Theater 1
  Industry-Sponsored Events

Attendees (98)